PFNX stock forecast
Our latest prediction for Pfenex, Inc.'s stock price was made on the Sept. 29, 2020 when the stock price was at 12.76$.
In the short term (2weeks), PFNX's stock price should underperform the market by -1.85%. During that period the price should oscillate between -7.22% and +6.45%.
In the medium term (3months), PFNX's stock price should underperform the market by -7.21%. During that period the price should oscillate between -26.54% and +19.09%.
Get email alertsCreate a solid portfolio with PFNX
About Pfenex, Inc.
Pfenex, Inc. is a development and licensing Biotechnology Company, which focuses on leveraging its Pfenex Expression Technology platform for developing and improving protein therapies. Its products include PF708, PF743, PF745, CRM197, PF810, PF753 and PFXX. The company was founded on November 19, 2009 and is headquartered in San Diego, CA.
At the moment the company generates 41M USD in revenues.
On its last earning announcement, the company reported a loss of -0.15$ per share.
The book value per share is 1.76$
Three months stock forecastSept. 29, 2020
Financials
Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
---|---|---|---|---|---|---|---|---|---|---|---|---|
41M | 92.20% | -6M | -14.40% | -6M | -0.15 | - | - | 33M | 1.76 | -4M | -2M | -6M |